Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

Regular physical activity helps cancer patients manage fatigue, pain, brain fog, emotional distress, and heart damage during ...

In February, the podcast host revealed doctors had found 'multiple' tumors on her brain and lung after a skin cancer ...

Nuvation Bio's taletrectinib shows strong efficacy in ROS1-positive NSCLC, with a 90.1% response rate. Click here to find out ...

Dawn had always been very healthy and active. So, when she began to experience some uncomfortable workouts and difficulty ...

Raymond Osarogiagbon, MD, shares practical strategies for clinicians and health systems to boost lung cancer screening rates among eligible patients.

The development of second tumors is influenced by several factors. These include the type and intensity of treatment received ...

Dr. Armine Smith discusses the importance of personalized therapeutic approaches for the treatment of urologic cancers, such ...

Q1 2025 Earnings Call Transcript April 30, 2025 Operator: Ladies and gentlemen, thank you for standing by, and welcome to ...

Although lung cancer screening ... A Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions Mar. 17, 2025 — In the continuing evolution of personalized medicine, a new study has ...

Blocking proteins that cause cancer cells to mutate and resist treatment could significantly improve outcomes for some ...

Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a ...